Edwards Lifesciences Corporation Cost of Revenue
Edwards Lifesciences Corporation (EW) reported Cost of Revenue of $392.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-04
- Edwards Lifesciences Corporation cost of goods and services sold for the quarter ending 2026-06-30 was $392.40M, a 13.94% increase year-over-year.
- Edwards Lifesciences Corporation cost of goods and services sold for the quarter ending 2026-03-31 was $362.60M, a 20.23% increase year-over-year.
- Edwards Lifesciences Corporation cost of goods and services sold for the quarter ending 2025-12-31 was $343.00M, a 17.39% increase year-over-year.
- Edwards Lifesciences Corporation cost of goods and services sold for the quarter ending 2025-09-30 was $345.20M, a 31.30% increase year-over-year.
- Edwards Lifesciences Corporation cost of goods and services sold for fiscal 2025 was $1.33B, a 19.39% increase from fiscal 2024.
- Edwards Lifesciences Corporation cost of goods and services sold for fiscal 2024 was $1.12B, a 14.22% increase from fiscal 2023.
- Edwards Lifesciences Corporation cost of goods and services sold for fiscal 2023 was $978.40M, a 35.19% increase from fiscal 2022.
- Edwards Lifesciences Corporation cost of goods and services sold for fiscal 2022 was $723.70M, a 42.05% decline from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $392.40M 10-Q · filed 2026-08-04 | $755.00M 10-Q · filed 2026-08-04 | $1.10B derived: sum of 3 quarters · filed 2026-08-04 | $1.44B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $362.60M 10-Q · filed 2026-05-06 | $705.60M derived: sum of 2 quarters · filed 2026-05-06 | $1.05B derived: sum of 3 quarters · filed 2026-05-06 | $1.40B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $343.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $688.20M derived: sum of 2 quarters · filed 2026-02-25 | $1.03B derived: sum of 3 quarters · filed 2026-08-04 | $1.33B 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $345.20M 10-Q · filed 2025-11-05 | $689.60M derived: sum of 2 quarters · filed 2026-08-04 | $991.20M 10-Q · filed 2025-11-05 | $1.28B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $344.40M 10-Q · filed 2026-08-04 | $646.00M 10-Q · filed 2026-08-04 | $938.20M derived: sum of 3 quarters · filed 2026-08-04 | $1.20B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $301.60M 10-Q · filed 2026-05-06 | $593.80M derived: sum of 2 quarters · filed 2026-05-06 | $856.70M derived: sum of 3 quarters · filed 2026-05-06 | $1.13B derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $292.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $555.10M derived: sum of 2 quarters · filed 2026-02-25 | $830.60M derived: sum of 3 quarters · filed 2026-02-25 | $1.12B 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $262.90M 10-Q · filed 2025-11-05 | $538.40M derived: sum of 2 quarters · filed 2025-11-05 | $825.30M 10-Q · filed 2025-11-05 | $1.08B derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $275.50M 10-Q · filed 2025-08-06 | $285.30M 10-Q · filed 2024-07-31 | $562.40M 10-Q · filed 2025-08-06 | $581.60M 10-Q · filed 2024-07-31 | $813.40M derived: sum of 3 quarters · filed 2026-02-25 | $1.06B derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | $286.90M 10-Q · filed 2025-05-06 | $385.60M 10-Q · filed 2024-04-29 | $537.90M derived: sum of 2 quarters · filed 2026-02-25 | $788.50M derived: sum of 3 quarters · filed 2026-02-25 | $1.05B derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | $251.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $501.60M derived: sum of 2 quarters · filed 2026-02-25 | $758.50M derived: sum of 3 quarters · filed 2026-02-25 | $978.40M 10-K · filed 2026-02-25 | $1.38B 10-K · filed 2024-02-12 | |||
| 2023-09-30 | $250.60M 10-Q · filed 2024-11-06 | $350.40M 10-Q · filed 2023-10-27 | $507.50M derived: sum of 2 quarters · filed 2024-11-06 | $727.40M 10-Q · filed 2024-11-06 | $1.02B 10-Q · filed 2023-10-27 | $738.20M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | $256.90M 10-Q · filed 2024-07-31 | $343.00M 10-Q · filed 2023-07-28 | $495.90M 10-Q · filed 2024-07-31 | $672.50M 10-Q · filed 2023-07-28 | $487.60M derived: sum of 3 quarters · filed 2025-02-28 | $741.40M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | $329.50M 10-Q · filed 2024-04-29 | $230.70M derived: sum of 2 quarters · filed 2025-02-28 | $484.50M derived: sum of 3 quarters · filed 2025-02-28 | $753.90M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | -$98.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $155.00M derived: sum of 2 quarters · filed 2025-02-28 | $424.40M derived: sum of 3 quarters · filed 2025-02-28 | $723.70M 10-K · filed 2025-02-28 | $1.08B 10-K · filed 2023-02-13 | |||
| 2022-09-30 | $253.80M 10-Q · filed 2023-10-27 | $523.20M derived: sum of 2 quarters · filed 2023-10-27 | $822.50M 10-Q · filed 2023-10-27 | $1.13B derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-06-30 | $269.40M 10-Q · filed 2023-07-28 | $568.70M 10-Q · filed 2023-07-28 | $878.20M derived: sum of 3 quarters · filed 2024-02-12 | $1.19B derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-03-31 | $299.30M 10-Q · filed 2023-04-28 | $608.80M derived: sum of 2 quarters · filed 2024-02-12 | $920.50M derived: sum of 3 quarters · filed 2024-02-12 | $1.25B derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2021-12-31 | $309.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $621.20M derived: sum of 2 quarters · filed 2024-02-12 | $955.50M derived: sum of 3 quarters · filed 2024-02-12 | $1.25B 10-K · filed 2024-02-12 | ||||
| 2021-09-30 | $311.70M 10-Q · filed 2022-10-28 | $646.00M derived: sum of 2 quarters · filed 2022-10-28 | $939.40M 10-Q · filed 2022-10-28 | $1.24B derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-06-30 | $334.30M 10-Q · filed 2022-07-29 | $627.70M 10-Q · filed 2022-07-29 | $924.00M derived: sum of 3 quarters · filed 2023-02-13 | $1.21B derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-03-31 | $293.40M 10-Q · filed 2022-04-28 | $589.70M derived: sum of 2 quarters · filed 2023-02-13 | $870.70M derived: sum of 3 quarters · filed 2023-02-13 | $1.11B derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2020-12-31 | $296.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $577.30M derived: sum of 2 quarters · filed 2023-02-13 | $815.50M derived: sum of 3 quarters · filed 2023-02-13 | $1.08B 10-K · filed 2023-02-13 | ||||
| 2020-09-30 | $281.00M 10-Q · filed 2021-10-29 | $519.20M derived: sum of 2 quarters · filed 2021-10-29 | $784.30M 10-Q · filed 2021-10-29 | $1.07B derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-06-30 | $238.20M 10-Q · filed 2021-07-30 | $503.30M 10-Q · filed 2021-07-30 | $789.50M derived: sum of 3 quarters · filed 2022-02-14 | $1.08B derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-03-31 | $265.10M 10-Q · filed 2021-04-28 | $551.30M derived: sum of 2 quarters · filed 2022-02-14 | $843.70M derived: sum of 3 quarters · filed 2022-02-14 | $1.15B derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2019-12-31 | $286.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $578.60M derived: sum of 2 quarters · filed 2022-02-14 | $882.60M derived: sum of 3 quarters · filed 2022-02-14 | $1.11B 10-K · filed 2022-02-14 | ||||
| 2019-09-30 | $292.40M 10-Q · filed 2020-10-26 | $596.40M derived: sum of 2 quarters · filed 2020-10-26 | $828.20M 10-Q · filed 2020-10-26 | $1.06B derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | $304.00M 10-Q · filed 2020-07-27 | $535.80M 10-Q · filed 2020-07-27 | $770.50M derived: sum of 3 quarters · filed 2021-02-12 | $995.40M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | $231.80M 10-Q · filed 2020-04-28 | $466.50M derived: sum of 2 quarters · filed 2021-02-12 | $691.40M derived: sum of 3 quarters · filed 2021-02-12 | $937.60M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | $234.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $459.60M derived: sum of 2 quarters · filed 2021-02-12 | $705.80M derived: sum of 3 quarters · filed 2021-02-12 | $939.40M 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | $224.90M 10-Q · filed 2019-10-25 | $471.10M derived: sum of 2 quarters · filed 2019-10-25 | $704.70M 10-Q · filed 2019-10-25 | $940.00M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-06-30 | $246.20M 10-Q · filed 2019-07-26 | $479.80M 10-Q · filed 2019-07-26 | $715.10M derived: sum of 3 quarters · filed 2020-02-14 | $928.40M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-03-31 | $233.60M 10-Q · filed 2019-04-26 | $468.90M derived: sum of 2 quarters · filed 2020-02-14 | $682.20M derived: sum of 3 quarters · filed 2020-02-14 | $893.30M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2017-12-31 | $235.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $448.60M derived: sum of 2 quarters · filed 2020-02-14 | $659.70M derived: sum of 3 quarters · filed 2020-02-14 | $875.30M 10-K · filed 2020-02-14 | ||||
| 2017-09-30 | $213.30M 10-Q · filed 2018-10-26 | $424.40M derived: sum of 2 quarters · filed 2018-10-26 | $640.00M 10-Q · filed 2018-10-26 | $853.20M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2017-06-30 | $211.10M 10-Q · filed 2018-07-27 | $426.70M 10-Q · filed 2018-07-27 | $639.90M derived: sum of 3 quarters · filed 2019-02-15 | $841.30M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2017-03-31 | $215.60M 10-Q · filed 2018-04-27 | $428.80M derived: sum of 2 quarters · filed 2019-02-15 | $630.20M derived: sum of 3 quarters · filed 2019-02-15 | $832.70M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2016-12-31 | $213.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $414.60M derived: sum of 2 quarters · filed 2019-02-15 | $617.10M derived: sum of 3 quarters · filed 2019-02-15 | $797.40M 10-K · filed 2019-02-15 | ||||
| 2016-09-30 | $201.40M 10-Q · filed 2017-10-27 | $403.90M derived: sum of 2 quarters · filed 2017-10-27 | $584.20M 10-Q · filed 2017-10-27 | $760.10M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-06-30 | $202.50M 10-Q · filed 2017-07-28 | $382.80M 10-Q · filed 2017-07-28 | $558.70M derived: sum of 3 quarters · filed 2018-02-16 | $705.40M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-03-31 | $180.30M 10-Q · filed 2017-04-28 | $356.20M derived: sum of 2 quarters · filed 2018-02-16 | $502.90M derived: sum of 3 quarters · filed 2018-02-16 | $661.50M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2015-12-31 | $175.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $322.60M derived: sum of 2 quarters · filed 2018-02-16 | $481.20M derived: sum of 3 quarters · filed 2018-02-16 | $617.20M 10-K · filed 2018-02-16 | ||||
| 2015-09-30 | $146.70M 10-Q · filed 2016-10-28 | $305.30M derived: sum of 2 quarters · filed 2016-10-28 | $441.30M 10-Q · filed 2016-10-28 | $601.70M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | $158.60M 10-Q · filed 2016-07-29 | $294.60M 10-Q · filed 2016-07-29 | $455.00M derived: sum of 3 quarters · filed 2017-02-17 | $623.10M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | $136.00M 10-Q · filed 2016-04-29 | $296.40M derived: sum of 2 quarters · filed 2017-02-17 | $464.50M derived: sum of 3 quarters · filed 2017-02-17 | $615.70M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | $160.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $328.50M derived: sum of 2 quarters · filed 2017-02-17 | $479.70M derived: sum of 3 quarters · filed 2017-02-17 | $625.60M 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | $168.10M 10-Q · filed 2015-10-29 | $319.30M derived: sum of 2 quarters · filed 2015-10-29 | $465.20M 10-Q · filed 2015-10-29 | $609.00M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $151.20M 10-Q · filed 2015-07-29 | $297.10M 10-Q · filed 2015-07-29 | $440.90M derived: sum of 3 quarters · filed 2016-02-19 | $569.10M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $145.90M 10-Q · filed 2015-04-29 | $289.70M derived: sum of 2 quarters · filed 2016-02-19 | $417.90M derived: sum of 3 quarters · filed 2016-02-19 | $541.50M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $143.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $272.00M derived: sum of 2 quarters · filed 2016-02-19 | $395.60M derived: sum of 3 quarters · filed 2016-02-19 | $516.60M 10-K · filed 2016-02-19 | $522.40M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $128.20M 10-Q · filed 2014-10-31 | $129.70M 10-Q · filed 2013-11-07 | $251.80M derived: sum of 2 quarters · filed 2014-10-31 | $372.80M 10-Q · filed 2014-10-31 | $376.90M 10-Q · filed 2013-11-07 | $495.00M derived: sum of 4 quarters · filed 2015-02-20 | ||
| 2013-06-30 | $123.60M 10-Q · filed 2014-08-04 | $125.00M 10-Q · filed 2013-08-06 | $244.60M 10-Q · filed 2014-08-04 | $247.20M 10-Q · filed 2013-08-06 | $366.80M derived: sum of 3 quarters · filed 2015-02-20 | $478.50M derived: sum of 4 quarters · filed 2015-02-20 | ||
| 2013-03-31 | $121.00M 10-Q · filed 2014-05-02 | $122.20M 10-Q · filed 2013-05-06 | $243.20M derived: sum of 2 quarters · filed 2015-02-20 | $354.90M derived: sum of 3 quarters · filed 2015-02-20 | $484.70M derived: sum of 4 quarters · filed 2015-02-20 | |||
| 2012-12-31 | $122.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | $233.90M derived: sum of 2 quarters · filed 2015-02-20 | $363.70M derived: sum of 3 quarters · filed 2015-02-20 | $491.00M 10-K · filed 2015-02-20 | $494.60M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $111.70M 10-Q · filed 2013-11-07 | $241.50M derived: sum of 2 quarters · filed 2013-11-07 | $368.80M 10-Q · filed 2013-11-07 | $488.40M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $129.80M 10-Q · filed 2013-08-06 | $257.10M 10-Q · filed 2013-08-06 | $376.70M derived: sum of 3 quarters · filed 2014-02-28 | $502.30M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $127.30M 10-Q · filed 2013-05-06 | $246.90M derived: sum of 2 quarters · filed 2014-02-28 | $372.50M derived: sum of 3 quarters · filed 2014-02-28 | $500.30M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $119.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $245.20M derived: sum of 2 quarters · filed 2014-02-28 | $373.00M derived: sum of 3 quarters · filed 2014-02-28 | $489.80M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $125.60M 10-Q · filed 2012-11-07 | $253.40M derived: sum of 2 quarters · filed 2012-11-07 | $370.20M 10-Q · filed 2012-11-07 | $483.70M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $127.80M 10-Q · filed 2012-08-07 | $244.60M 10-Q · filed 2012-08-07 | $358.10M derived: sum of 3 quarters · filed 2013-02-28 | $453.90M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $116.80M 10-Q · filed 2012-05-09 | $230.30M derived: sum of 2 quarters · filed 2013-02-28 | $326.10M derived: sum of 3 quarters · filed 2013-02-28 | $426.50M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $113.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $209.30M derived: sum of 2 quarters · filed 2013-02-28 | $309.70M derived: sum of 3 quarters · filed 2013-02-28 | $408.30M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $95.80M 10-Q · filed 2011-11-08 | $196.20M derived: sum of 2 quarters · filed 2011-11-08 | $294.80M 10-Q · filed 2011-11-08 | $396.50M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-06-30 | $100.40M 10-Q · filed 2011-08-08 | $199.00M 10-Q · filed 2011-08-08 | $300.70M derived: sum of 3 quarters · filed 2012-02-27 | $399.20M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-03-31 | $98.60M 10-Q · filed 2011-05-09 | $200.30M derived: sum of 2 quarters · filed 2012-02-27 | $298.80M derived: sum of 3 quarters · filed 2012-02-27 | $400.70M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2009-12-31 | $101.70M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $200.20M derived: sum of 2 quarters · filed 2012-02-27 | $302.10M derived: sum of 3 quarters · filed 2012-02-27 | $399.10M 10-K · filed 2012-02-27 | ||||
| 2009-09-30 | $98.50M 10-Q · filed 2010-11-08 | $200.40M derived: sum of 2 quarters · filed 2010-11-08 | $297.40M 10-Q · filed 2010-11-08 | |||||
| 2009-06-30 | $101.90M 10-Q · filed 2010-08-06 | $198.90M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | $419.60M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |